Literature DB >> 18270320

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.

Winnie S Liang1, Travis Dunckley, Thomas G Beach, Andrew Grover, Diego Mastroeni, Keri Ramsey, Richard J Caselli, Walter A Kukull, Daniel McKeel, John C Morris, Christine M Hulette, Donald Schmechel, Eric M Reiman, Joseph Rogers, Dietrich A Stephan.   

Abstract

Alzheimer's Disease (AD) is the most widespread form of dementia during the later stages of life. If improved therapeutics are not developed, the prevalence of AD will drastically increase in the coming years as the world's population ages. By identifying differences in neuronal gene expression profiles between healthy elderly persons and individuals diagnosed with AD, we may be able to better understand the molecular mechanisms that drive AD pathogenesis, including the formation of amyloid plaques and neurofibrillary tangles. In this study, we expression profiled histopathologically normal cortical neurons collected with laser capture microdissection (LCM) from six anatomically and functionally discrete postmortem brain regions in 34 AD-afflicted individuals, using Affymetrix Human Genome U133 Plus 2.0 microarrays. These regions include the entorhinal cortex, hippocampus, middle temporal gyrus, posterior cingulate cortex, superior frontal gyrus, and primary visual cortex. This study is predicated on previous parallel research on the postmortem brains of the same six regions in 14 healthy elderly individuals, for which LCM neurons were similarly processed for expression analysis. We identified significant regional differential expression in AD brains compared with control brains including expression changes of genes previously implicated in AD pathogenesis, particularly with regard to tangle and plaque formation. Pinpointing the expression of factors that may play a role in AD pathogenesis provides a foundation for future identification of new targets for improved AD therapeutics. We provide this carefully phenotyped, laser capture microdissected intraindividual brain region expression data set to the community as a public resource.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270320      PMCID: PMC2826117          DOI: 10.1152/physiolgenomics.00242.2007

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  143 in total

Review 1.  The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases.

Authors:  H Braak; E Braak
Journal:  Neurosci Res       Date:  1992-10       Impact factor: 3.304

2.  Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

Authors:  H Yamaguchi; K Ishiguro; T Uchida; A Takashima; C A Lemere; K Imahori
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

Review 3.  Cerebral metabolic changes in Alzheimer's disease: neurobehavioral patterns.

Authors:  R Blesa; E Mohr; R S Miletich; K Hildebrand; M Sampson; T N Chase
Journal:  Dementia       Date:  1996 Sep-Oct

4.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

5.  Tmp21 and p24A, two type I proteins enriched in pancreatic microsomal membranes, are members of a protein family involved in vesicular trafficking.

Authors:  R Blum; P Feick; M Puype; J Vandekerckhove; R Klengel; W Nastainczyk; I Schulz
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

6.  alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease.

Authors:  J Xiao; G Perry; J Troncoso; M J Monteiro
Journal:  J Neuropathol Exp Neurol       Date:  1996-09       Impact factor: 3.685

7.  The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.

Authors:  C A Lemere; F Lopera; K S Kosik; C L Lendon; J Ossa; T C Saido; H Yamaguchi; A Ruiz; A Martinez; L Madrigal; L Hincapie; J C Arango; D C Anthony; E H Koo; A M Goate; D J Selkoe; J C Arango
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

8.  Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation.

Authors:  N C Fox; E K Warrington; J M Stevens; M N Rossor
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

9.  Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes.

Authors:  N Goode; K Hughes; J R Woodgett; P J Parker
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  133 in total

1.  Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence.

Authors:  Jia Yao; Ryan T Hamilton; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Biochim Biophys Acta       Date:  2010-06-09

Review 2.  γ-Secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease.

Authors:  Kohzo Nakayama; Hisashi Nagase; Chang-Sung Koh; Takeshi Ohkawara
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 3.  Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.

Authors:  Walter J Lukiw; Peter N Alexandrov
Journal:  Mol Neurobiol       Date:  2012-08       Impact factor: 5.590

4.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

Review 5.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

Review 6.  Single-cell and regional gene expression analysis in Alzheimer's disease.

Authors:  Ruby Kwong; Michelle K Lupton; Michal Janitz
Journal:  Cell Mol Neurobiol       Date:  2012-01-22       Impact factor: 5.046

7.  The Alzheimer's associated 5' region of the SORL1 gene cis regulates SORL1 transcripts expression.

Authors:  Jeanette J McCarthy; Sunita Saith; Colton Linnertz; James R Burke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek
Journal:  Neurobiol Aging       Date:  2010-12-23       Impact factor: 4.673

8.  Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function.

Authors:  Diego Mastroeni; Omar M Khdour; Pablo M Arce; Sidney M Hecht; Paul D Coleman
Journal:  ACS Chem Neurosci       Date:  2015-02-24       Impact factor: 4.418

9.  Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.

Authors:  Dennis Dik-Long Chau; Kristen Wing-Yu Yung; William Wai-Lun Chan; Ying An; Yan Hao; Ho-Yin Edwin Chan; Jacky Chi-Ki Ngo; Kwok-Fai Lau
Journal:  FASEB J       Date:  2019-08-05       Impact factor: 5.191

10.  Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients.

Authors:  Leonidas Chouliaras; Diego Mastroeni; Elaine Delvaux; Andrew Grover; Gunter Kenis; Patrick R Hof; Harry W M Steinbusch; Paul D Coleman; Bart P F Rutten; Daniel L A van den Hove
Journal:  Neurobiol Aging       Date:  2013-04-09       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.